Fundalysisby DARKHORSESTOCKS

Scheme

ITI Pharma and Healthcare Fund

Holds 37 companies worth ₹264 Cr in Sept 2026.

  • Fund house

    ITIThe fund house that runs this scheme.

  • AUM

    ₹266 CrITI Pharma and Healthcare Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Down 3.7% on Aug 2026, ₹276 Cr.

  • Largest holding

    Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 12.0% of this scheme's NAV.

  • Fund manager

    Nilay DalalRuns it since 8 May 2026, as the fund house dates it. With Animesh Singh (fund manager).

AUM(Dec 2021 – Sept 2026)

AUM at month end each month, and its change on the month before
12 months₹ CrChange
Sept 2026266−3.7%
Aug 2026276+5.1%
Jul 2026263+4.4%
Jun 2026252+5.9%
May 2026238+3.7%
Apr 2026230+8.7%
Mar 2026211−4.8%
Feb 2026222+5.5%
Jan 2026210−6.0%
Dec 2025224−3.1%
Nov 2025231−0.9%
Oct 2025233+2.8%
AUM at month end, Sept 2026
₹266 Cr
+14.3% since Oct 2025
Fig. 1.AUM at each month's end, ₹ crore; under All, the quarterly average since 2010. Source: AMFI.

Direct plans(Dec 2021 – Sept 2026)

Direct plans' share of AUM each quarter, and its change on the quarter before
4 quartersShareChange
Sept 20268.07%−0.09 pt
Jun 20268.16%+0.14 pt
Mar 20268.02%+0.14 pt
Dec 20257.88%+0.23 pt
Direct plans' share of AUM, Sept 2026
8.07%
+0.19 pt since Dec 2025
Fig. 2.ITI Pharma and Healthcare Fund's quarterly average AUM in direct plans, which pay no distributor; changes in points. Source: AMFI.

Returns(9 Oct 2026)

Growth · Direct and Regular plans

To 9 Oct 2026; past a year, a yearly rate. Benchmark: NIFTY Healthcare TRI. * From NAVs. Source: AMFI. Click a column's header to sort by it.
1 month *
−5.02%−5.15%––−4.51%
3 months *
−0.85%−1.28%––−3.15%
6 months *
+15.63%+14.65%––+4.22%
1 year
+8.22%+6.29%+9.18%−0.96 pt+0.43%
3 years
+18.72%+16.54%+19.13%−0.41 pt+12.61%
Since launch
+13.99%+11.75%+13.89%+0.10 pt+13.17%
Fig. 3.To 9 Oct 2026; past a year, a yearly rate. Benchmark: NIFTY Healthcare TRI. * From NAVs. Source: AMFI.